AeroLeads people directory · profile

John Bamforth Phd Email & Phone Number

Executive Director, Eshelman Innovation at Cape Fear BioCapital
Location: Chapel Hill, North Carolina, United States 15 work roles 3 schools
2 work emails found @lilly.com 5 phones found area 317 and 865 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails · 5 phones

Work email b****@lilly.com
Direct phone (317) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Executive Director, Eshelman Innovation
Location
Chapel Hill, North Carolina, United States
Company size

Who is John Bamforth Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

John Bamforth Phd is listed as Executive Director, Eshelman Innovation at Cape Fear BioCapital, a company with 2 employees, based in Chapel Hill, North Carolina, United States. AeroLeads shows a work email signal at lilly.com, phone signal with area code 317, 865, and a matched LinkedIn profile for John Bamforth Phd.

John Bamforth Phd previously worked as Executive Director at Eshelman Innovation and Board Member at Humacyte. John Bamforth Phd holds Dsc, Honorary from Aston University.

Company email context

Email format at Cape Fear BioCapital

This section adds company-level context without repeating John Bamforth Phd's masked contact details.

*@lilly.com
71% confidence

AeroLeads found 2 current-domain work email signals for John Bamforth Phd. Compare company email patterns before reaching out.

Profile bio

About John Bamforth Phd

Executive Innovation, Entrepreneurial and Commercial Leader who has extensive experience in new business creation, innovation, and global campaigns, culminating in the most recent work as Director, Eshelman Institute for Innovation and previously as Chief Marketing Officer for Lilly's Global Brands. Successfully launched new innovations today and brands throughout early career. Considered instrumental in the strategic development of small company breakthroughs to major global blockbusters. Deep pharmaceutical and healthcare background with knowledge of small innovations to large Pharma business insights.

Listed skills include Leadership, Marketing Management, Osteoporosis, Personnel Management, and 31 others.

Current workplace

John Bamforth Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Cape Fear BioCapital
Cape Fear Biocapital
Executive Director, Eshelman Innovation
Chapel Hill, NC, US
Employees
2
AeroLeads page
15 roles · 15 years

John Bamforth Phd work experience

A career timeline built from the work history available for this profile.

Executive Director

Current

Chapel Hill, North Carolina, US

Oct 2019 - Present

Board Member

Current

Durham, NC, US

Jun 2024 - Present

Board Member

Current

Board Member of READDI. A public-private partnership to develop 5 novel broad spectrum anti-virals for the next pandemic. Acting as interim Executive Director and President.

Sep 2020 - Present

Co-Founder

Current
Ciara Arts And Science Foundation

Founded a family foundation to support the educational needs of disadvantaged youth in the Indianapolis and South Florida communities. Primary focus is scholarships in the Arts and Science.

May 2017 - Present

Chairman Of The Board

Current
Akanocure Pharmaceuticals

Bioinspired Drug Development..... Enabled by Chemistry

Dec 2018 - Present

Board Member

Knoxville, TN, US

Founding board member of local non-profit charity. Secretary of the board that made the Indianapolis brand of the charity the most productive in the Country.

Jun 2016 - Dec 2019

Vp Cmo Lilly Biomedicines

Indianapolis, Indiana, US

  • Total focus in this high-profile worldwide role includes planning, comprehensive review and global execution of all therapeutic area strategies. Selected highlights include building new brand teams focused on creating.
  • Took over the refinement and strategic revision of immunology and pain TAs for Lilly. Cross functional effort required and continues to require extensive planning; current projected outcomes include a brand new 5-10.
  • Led the commercial assessment and worked with BD to acquire CoLucid for $960M. Brand will be the first new acute med to launch in migraine for 20 years.
  • Successfully developed, created and supervised the first two global launches in immunology for Lilly. Focused work in this area has required a combination of building high quality marketing teams, working seamlessly.
  • Appointed to and currently serving as LLY Chair of joint steering committee in LLY/PFE Alliance on a monoclonal antibody for chronic pain.
Jan 2017 - Sep 2018

Chief Marketing Officer, Lilly Usa

Indianapolis, Indiana, US

  • Led a team of 250 marketers across Eli Lilly’s US business. Picked up a disengaged team and turned them into a high performing team of engaged marketers. Developed, managed, and oversaw business for LillyUSA..
  • Exceeded revenue targets all fours years in the affiliate.
  • Delivered digital marketing strategy for the affiliate; recognized for transforming operatIons as an enterprise around technology by powerfully partnering with IT and transforming web properties. Built a social.
  • Turned around performance of two declining brands in 6 months. CNS brand had been in decline for 7 years. Recreated the entire leadership team for each brand, revising and simplifying the strategy; clearly identified.
  • Integral team member on program that delivered the single largest restructure in affiliate’s history.
Oct 2012 - Dec 2016

Senior Director, Global Franchises

Indianapolis, Indiana, US

  • Gained ED market leadership with WW with core ED brand (Revenue >$2Bn). Was able to align the majority of affiliates to our global strategy, gain significant investments in lifecycle and commercial spend to drive.
  • Licensed PAH brand to UT in the US – identified PAH/orphan disease not core competency. Thoroughly developed competitive process to successfully identify partner.
  • Licensed novel under arm testosterone. – in building out urology business identified a novel application of TRT for the same target doctors from a small biotech in Melbourne, Australia. Again, built a strong, long-term.
  • Acquisition of ED Biotech for $2.1B. Having successfully launched ED brand we determined acquisition was the best strategy for the long-term. As part of the deal team worked closely with the partner's CEO & CFO to.
Jul 2009 - Oct 2012

Global Marketing Director

Indianapolis, Indiana, US

  • Provided international leadership, focus, operations and strategy for maximizing revenue growth and market share for ED Brand worldwide. Highlights include:
  • Highly successfully launched ED Brand WW and delivered above expectations for 5 consecutive years.
  • Team awarded Marketing Team of the Year on three occasions (2 internally, one externally).http://www.stevieawards.com/pubs/awards/70_1871_11715.cfm
Jan 2003 - Jun 2009

Neuroscience Global Marketing Strategy

Indianapolis, Indiana, US

  • Provided international leadership, focus, operations and strategy for maximizing revenue growth and market share for Key CNS brand worldwide. Highlights include:
  • Delivered review of brand strategy and development of first Global Marketing campaign.
  • Awarded MVP award on team in 2002.
Apr 2001 - Jan 2003

Sales And Marketing Roles (Various)

Indianapolis, Indiana, US

  • Returned key CNS brand to growth in the UK within six months of appointment in 2000. Brand was in decline after 2 years in market, identified strategy, focus and alignment issues with the leadership team. Personally.
  • Launched first two insulin pen devices in the UK during a period of unprecedented growth for Lilly Diabetes UK.
  • Named Sales Representative of the Year 1991. In two years took territory to #1 in the country.
Oct 1989 - Apr 2001

Board Of Trustees

Indianapolis, Indiana, US

Was an active Board member at the school for six years. Worked to successfully address enrolment shortfall through the development of a marketing plan for the school and establishing a scholarship program with the Center for Leadership Development.

2011 - 2016 ~5 yrs
3 education records

John Bamforth Phd education

Dsc, Honorary

Aston University

Phd, Neuropharmacology

Aston University

Bpharm, Pharmacy

University Of Bath
FAQ

Frequently asked questions about John Bamforth Phd

Quick answers generated from the profile data available on this page.

What company does John Bamforth Phd work for?

John Bamforth Phd works for Cape Fear BioCapital.

What is John Bamforth Phd's role at Cape Fear BioCapital?

John Bamforth Phd is listed as Executive Director, Eshelman Innovation at Cape Fear BioCapital.

What is John Bamforth Phd's email address?

AeroLeads has found 2 work email signals at @lilly.com for John Bamforth Phd at Cape Fear BioCapital.

What is John Bamforth Phd's phone number?

AeroLeads has found 5 phone signal(s) with area code 317, 865 for John Bamforth Phd at Cape Fear BioCapital.

Where is John Bamforth Phd based?

John Bamforth Phd is based in Chapel Hill, North Carolina, United States while working with Cape Fear BioCapital.

What companies has John Bamforth Phd worked for?

John Bamforth Phd has worked for Cape Fear Biocapital, Eshelman Innovation, Humacyte, Readdi, and Ciara Arts And Science Foundation.

How can I contact John Bamforth Phd?

You can use AeroLeads to view verified contact signals for John Bamforth Phd at Cape Fear BioCapital, including work email, phone, and LinkedIn data when available.

What schools did John Bamforth Phd attend?

John Bamforth Phd holds Dsc, Honorary from Aston University.

What skills is John Bamforth Phd known for?

John Bamforth Phd is listed with skills including Leadership, Marketing Management, Osteoporosis, Personnel Management, Cardiology, Sales, Market Planning, and Biotechnology.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.